Compass Inc. Class A Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? Compass Inc. Class A Common Stock trades at $9.52 (market cap $7.05B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 3.6× Compass Inc. Class A Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Compass Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Compass Inc. Class A Common Stock for 0 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| COMP | ROIV | |
|---|---|---|
Market Cap | $7.05B | $25.09B |
Volume | 15,310,192 | 5,738,571 |
Sector | Real Estate | Health |
52-Week High | $13.58 | $41.81 |
52-Week Low | $6.68 | $16.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.47B | $21.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Compass is a technology-enabled residential real estate company. Its platform provides agents with tools for customer relationships, marketing, client service, and transactions, alongside brokerage, title, escrow, and mortgage services.
Read more on COMP →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →